Compounds > triethylenephosphoramide
Page last updated: 2024-08-21

triethylenephosphoramide and Hematologic Malignancies

triethylenephosphoramide has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Accogli, MA; Costi, S; Denti, M; Fugazzaro, S1

Trials

1 trial(s) available for triethylenephosphoramide and Hematologic Malignancies

ArticleYear
Therapeutic education and physical activity are feasible and safe in hematologic cancer patients referred to chemotherapy: results of a randomized controlled trial.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022, Dec-19, Volume: 31, Issue:1

    Topics: Exercise; Fatigue; Hematologic Neoplasms; Humans; Pilot Projects; Quality of Life; Triethylenephosphoramide

2022